Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

My Subscriptions My Account My Orders Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Estimates
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Liabilities and Shareholders Equity Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Receivables Retained Earnings Shareholder's Equity Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Receivables Depreciation & Amortization (CF)Depreciation and Depletion Dividends Paid - Common Exchange Rate Effect Free Cash Flow Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Income Non-cash Items Other financing activities Sales of Property, Plant and Equipment Share-based Compensation Shares Issued

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Market Capitalization Price Price to Earnings Price to Sales

Growth Metrics

EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Gross Profit Income from Continuing Operations Income towards Parent Company Interest & Investment Income Interest Expenses Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Other Operating Expenses Preferred Dividend Payments Profit After Tax Research & Development Restructuring Costs Revenue Selling, General & Administrative Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)

Others

Accumulated Depreciation & Amortization Amortization - Deferred Charges Cost of Revenue Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)R&D In Process Receivables - Net Receivables - Other Revenue - Other Shares Repurchased

Ratios

Asset Utilization Ratio Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin FCF Payout Ratio Gross Margin Interest Coverage Ratio Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales Times Interest Earned

Cardiff Oncology (CRDF) Notes Payables (2020)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Cardiff Oncology's Notes Payables history spans 1 years, with the latest figure at $305000.0 for Q3 2020.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount